Benefits to Canada
CPHIN is projected to create more than 1,900 good-paying jobs across Canada and contribute more than $232 million annually toward the nation’s GDP. These economic benefits will be felt in almost every province and territory.
The total impact of the CPHIN network is also expected to:
• Position companies to compete in a $425B global personalized healthcare market, generating both home-grown success stories and economic value for Canada;
• Attract private sector investment in personal healthcare initiatives generally (expected to increase by 33% over five years), and in clinical trials specifically (increase by 25% at certain sites); and
• Realize wage gains of $795M per year through improved treatment efficacy that helps people get back to work.
CPHIN will spur economic development by helping businesses capture a share of the quickly growing personalized healthcare market through the commercialization of new technologies, attracting greater R&D investment, and by making Canada a more attractive jurisdiction for life sciences businesses and professionals to relocate to.
CPHIN will assist the growth of early-stage Canadian companies. CPHIN has enlisted CQDM and Accel-Rx to create and implement an incubation and accelerator strategy to support and scale emerging life science startups.
CQDM will coordinate a network to help translate research into commercially viable technologies, while Accel-Rx will facilitate investment opportunities and knowledge transfer activities.
This strategy is being supported by MaRs Innovation and CDRD to improve its reach and impact.
Benefits to the Healthcare System
Today, divisions between provincial healthcare systems and between individual health organizations constrain the accessibility of care for Canadians. This division affects the ability of doctors to prescribe personalized treatments. CPHIN’s Integrated Data Network (IDN) will reduce barriers to information and, as a result, enable more patient-centric care.
When completed, the IDN will be Canada’s most-comprehensive health query network accessible to clinicians, researchers, the private sector, and all Canadian patients through their healthcare provider. As data from source institutions will be held in secure staging areas at individual sites, CPHIN’s platform will be able to send queries to each staging area. This will allow CPHIN’s users to access data without requiring that it be hosted it in one central location. Patient privacy and data security is at the core of the IDN’s design.
Altogether, the safe and timely transfer of information will improve:
• Access to health data and insights for Canadians in remote and isolated communities, who are often forced to travel long distances to receive quality care.
• Access to integrated data through CPHIN, which will allow clinicians to better tailor their approach for patients, leading to better health outcomes as treatments are aligned with the genomic makeup of patients.
Benefits to the Research Community
CPHIN’s IDN will be a revolutionary tool for both public and private sector researchers by serving as a ‘one-stop data shop’. The benefits to the research community include:
• Saving research time and money, allowing for more research to be done: Data collection is often the most time-consuming and expensive part of the research process. CPHIN will allow for data to be findable and accessible through one portal from any part of the country. Researchers will be able to focus more of their time and resources on solving pressing medical questions, instead of spending their time collecting data.
• Preventing repetitive research: Because information sharing is constrained, researchers with similar research questions at different institutions are forced to collect the same data individually. CPHIN will connect data from various institutions, preventing this duplication.
• Enabling real-time insights: The data will be delivered through the IDN in near real-time, rather than being months-to-years old. This will better position researchers to make ground-breaking discoveries, and will spur innovation as a result.
• Increasing clinical trial participation: The linked data will allow trial candidates to be identified more easily and faster. This will make the recruitment process more efficient, saving resources, and making Canada a more attractive jurisdiction to run trials, positioning the country as a global leader in therapeutic research.
Benefits to Patients
CPHIN’s core purpose is to empower patients to make better health decisions, working with their clinicians to receive treatments that are personalized to their genomic makeup.
The pivot to personalized healthcare will lead to better health outcomes for patients. Leading researchers, practitioners, and executives agree that personalized healthcare supported by robust data, carries the potential to revolutionize the way diseases are treated.